The North America Intragastric Balloon Market would witness market growth of 11.6% CAGR during the forecast period (2020-2026). The Intragastric balloon industry products are used widely for different purposes. The flattened gastric balloon is inserted into the stomach, through the esophagus. A needle is then used to seal the balloon with a saline solution that is sterilized. ReShape Dual Balloon Integrated System (ReShape Dual Balloon) is a dual balloon unit. The double-balloon device can provide a level of safety: when one balloon leaks or ruptures, a blue dye in the urine informs the patient that there is a problem.
The device, called the ReShape Dual Balloon (ReShape Medical), is inserted through the mouth endoscopically and then filled with saline. A gastric balloon is an effective device for kick-start weight loss, and when patients embrace smaller portion sizes and emphasis on lean proteins and vegetables, the balloons also result in diet and exercise alone doubling or tripling the weight loss.
The cost-effectiveness and safety of intragastric balloons would play an important role in market growth. The treatments for intragastric balloon implantation are safer and lower-cost alternatives to bariatric surgery, which is an invasive weight loss procedure that causes multiple risks after surgery. The cost of these procedures is also considerably higher than the intragastric balloons plantation. Therefore, non-surgical and less-invasive weight loss procedures such as intragastric balloon implantation are becoming increasingly common.
Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Intragastric Balloon Market in North America is expected to register a CAGR of 11.6% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.
Market Segmentation:
By Administration
By Type
By Filling Material
By End Use
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
